By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina reported on Tuesday after the close of the market a 45 percent increase in its fourth-quarter revenues, slightly above an estimate it provided last month and beating analysts' consensus estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.